All News about Axonics Inc
![](https://mms.businesswire.com/media/20220908005376/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220818005007/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® to Participate in September Investor Conferences
August 18, 2022
From Axonics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220817005035/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24052.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_10715.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220805005473/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220802006213/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Announces Pricing of Public Offering of Common Stock
August 02, 2022
From Axonics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13916.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220802006118/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Announces Proposed Public Offering of Common Stock
August 02, 2022
From Axonics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/08/02/aapharma_11.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7593.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7454.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220801005281/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Reports Second Quarter 2022 Financial Results
August 01, 2022
From Axonics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220711005237/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7415.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220531005190/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220505006004/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/options_image_1030.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220426005508/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220419005467/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_6756.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220414005813/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6332.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220404005257/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-gdd37bc5d2_1920_15.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3758.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/peek_into_the_marketnew_379.png)
![](https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/stocks_to_watch_2140.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/stocks_to_watch_2140.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.